Statement Of Cash Flows [Abstract]

BioInvent International - Filing #702054

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
278 444 SEK
278 444 SEK
76 333 SEK
76 333 SEK
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
12 769 SEK
1 301 SEK
Adjustments for depreciation and amortisation expense
14 610 SEK
12 004 SEK
Other adjustments for non-cash items
1 138 SEK
41,000 SEK
Interest paid, classified as operating activities
517,000 SEK
335,000 SEK
Interest received, classified as operating activities
248,000 SEK
28,000 SEK
Cash flows from (used in) operating activities
245 843 SEK
62 622 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
13 260 SEK
6 700 SEK
Cash flows from (used in) investing activities
467 542 SEK
6 700 SEK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
5 924 SEK
5 820 SEK
Cash flows from (used in) financing activities
894 870 SEK
644 617 SEK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
181 485 SEK
575 295 SEK
Cash and cash equivalents
910 755 SEK
729 270 SEK
729 270 SEK
153 975 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.